Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Significant Accounting Policies - Additional Information (Detail)

v3.25.1
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
 12 Months Ended
Jun. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Summary Of Significant Accounting Policies [Line Items]        
Common stock, par value   $ 0.001 $ 0.001  
Research and development expenses   $ 17,210,548 $ 13,618,348  
Cash and cash equivalents   56,500,000 9,200,000  
Allowance for doubtful accounts   0 0  
Accounts receivable   (0) (39,881) $ 39,881
Reverse stock split description we effected a reverse stock split at the ratio of 1 post-split share for every 6 pre-split shares      
Vendor [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Research and development expenses   307,000 76,000  
Payable balance to vendor   $ 0 $ 14,000  
Computer Equipment [Member] | Minimum        
Summary Of Significant Accounting Policies [Line Items]        
Estimated Useful Lives   three    
Office Equipment [Member] | Maximum        
Summary Of Significant Accounting Policies [Line Items]        
Estimated Useful Lives   five    
Customer Concentration Risk | Sales Revenue        
Summary Of Significant Accounting Policies [Line Items]        
Concentration risk, percentage   100.00% 100.00%